Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
03/04/2004 | WO2004017971A1 Use of a papaverine-like vasodilator and pharmaceutical composition |
03/04/2004 | WO2004017962A2 Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
03/04/2004 | WO2004017958A1 Soft capsule preparation |
03/04/2004 | WO2004017954A1 Agent for reducing side effects of diclofenac |
03/04/2004 | WO2004017951A1 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome |
03/04/2004 | WO2004017947A1 Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets |
03/04/2004 | WO2004017945A1 Nanoparticles for dna administration to a target organ |
03/04/2004 | WO2004017944A1 Liposomal gemcitabine compositions for better drug delivery |
03/04/2004 | WO2004017943A2 Non-vesicular cationic lipid formulations |
03/04/2004 | WO2004017942A1 Inhalation compositions with high drug ratios |
03/04/2004 | WO2004017941A2 Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist |
03/04/2004 | WO2004017940A2 Pharmaceutically active lipid based formulation of sn38 |
03/04/2004 | WO2004017938A2 Nitrofurantoin controlled release dosage form |
03/04/2004 | WO2004017937A1 Biodegradable composition with prolonged release of the biological active compound and preparation thereof |
03/04/2004 | WO2004017918A2 Method of preparing dry powder inhalation compositions |
03/04/2004 | WO2004017915A2 Composition for the carrying and delivery of bone growth inducing material and methods for producing and applying the composition |
03/04/2004 | WO2004017914A2 Inhalation composition |
03/04/2004 | WO2004017907A2 Blood clot-targeted nanoparticles |
03/04/2004 | WO2004017903A2 Methods for treating fungal infections |
03/04/2004 | WO2004017901A2 Compositions and methods for treating skin conditions |
03/04/2004 | WO2004017897A2 Aripiprazole complex formulation and method |
03/04/2004 | WO2004002445A3 Novel floating dosage form |
03/04/2004 | WO2003101427A8 Immunoliposomes formed with aggregated antibody |
03/04/2004 | WO2003095012B1 Method and apparatus for vaporizing a compound |
03/04/2004 | WO2003079993A3 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION |
03/04/2004 | WO2003075888A3 Materials containing multiple layers of vesicles |
03/04/2004 | WO2003072143A9 Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
03/04/2004 | WO2003060076A3 Povidone-containing carriers for polypeptide growth factors |
03/04/2004 | WO2003055442A3 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
03/04/2004 | WO2003053498A3 Medication delivery system and monitor |
03/04/2004 | WO2003053463A3 Poxvirus-containing compositions and process for their preparation |
03/04/2004 | WO2003053180A3 Undergarments containing active substances |
03/04/2004 | WO2003051286A3 Hydrogel compositions, devices, and microscale components |
03/04/2004 | WO2003043574A3 Pharmaceutical compositions in particulate form |
03/04/2004 | WO2003041687A3 Method for producing stable solutions of phenolic substances and resulting solutions |
03/04/2004 | WO2003039566A3 Methods of treatment in situ in the lungs of mammals |
03/04/2004 | WO2003032904A3 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
03/04/2004 | WO2003026629A3 Modified release dosage forms |
03/04/2004 | WO2003026581A3 Pharmaceutical compositions and methods for treating cancer |
03/04/2004 | WO2003015759A3 Treatment of hyperproliferative conditions of body surfaces |
03/04/2004 | WO2003005961A3 A controlled release biodegradable gel matrix |
03/04/2004 | WO2003000310A9 Nasal devices |
03/04/2004 | WO2002094178A3 Treatment of renal fibrosis |
03/04/2004 | WO2002085248A3 Prostanoids augment ocular drug penetration |
03/04/2004 | WO2002072606A3 Epitope testing using hla |
03/04/2004 | WO2002066000A3 Novel cosmetic slimming compositions containing boldine |
03/04/2004 | WO2002047664A8 Microparticles with an improved release profile and method for the production thereof |
03/04/2004 | WO2002036158A8 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses |
03/04/2004 | WO2002015938A8 Testosterone ester formulation for human use |
03/04/2004 | US20040044408 Cell-culture and polymer constructs |
03/04/2004 | US20040044332 Implantable medical device for delivering a liquid |
03/04/2004 | US20040044306 Pivoting joint infusion system with seal |
03/04/2004 | US20040044241 Novel succinate salt of O-desmethyl-venlafaxine |
03/04/2004 | US20040044196 Derivatised carbohydrates and their use in solid delivery systems |
03/04/2004 | US20040044185 Comprises transmembrane protein for use in liposome-based drug and nucleotide delivery systems; gene therapy |
03/04/2004 | US20040044086 Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism |
03/04/2004 | US20040044082 Adrenergic receptor antagonist |
03/04/2004 | US20040044080 Treatment of dyspareunia with topically administered nitroglycerin formulations |
03/04/2004 | US20040044078 Cosmetic and/or pharmaceutical emulsions |
03/04/2004 | US20040044070 Cardiovascular disorders; antiarrhythmia agents |
03/04/2004 | US20040044035 Antiallergens; rhinitis |
03/04/2004 | US20040044020 Respiratory system disorders; antiinflammatory agents |
03/04/2004 | US20040043996 Controlled release formulation of lamotrigine |
03/04/2004 | US20040043981 Pharmaceutical composistions |
03/04/2004 | US20040043980 Bactericides; storage stability |
03/04/2004 | US20040043964 Cellulosic particle for pharmaceuticals preparation |
03/04/2004 | US20040043954 Liposomes |
03/04/2004 | US20040043952 Complex of lipid and pentaerythritol; supplying nucleic acids to cells; transfection cells; drug delivery |
03/04/2004 | US20040043945 Crystal forms of azithromycin |
03/04/2004 | US20040043944 Form of azithromycin selected from the group consisting of forms D, E, substantially pure F, G, J, M substantially in the absence of azithromycin dihydrate, N, O, P, Q, and R; NMR spectrun analysis; bactericides; antiprotozoa agents; infections of mammals, birtds, and fish; drug resistance |
03/04/2004 | US20040043943 Method for the management of incontinence |
03/04/2004 | US20040043925 Cyclic depsipeptides; veterinary medicine |
03/04/2004 | US20040043171 Transdermal drug delivery |
03/04/2004 | US20040043079 Microencapsulated materials and method of making same |
03/04/2004 | US20040043078 Encapsulation of emulsions |
03/04/2004 | US20040043077 Production of microspheres |
03/04/2004 | US20040043076 Containing protein active material; solvent-free |
03/04/2004 | US20040043075 Topical applying; vision defects |
03/04/2004 | US20040043073 Mixture of wax and drug; sustained release |
03/04/2004 | US20040043071 Intravaginal mucosal or transmucosal delivery of antimigraine and antinausea drugs |
03/04/2004 | US20040043070 Hot melt coating by direct blending and coated substrates |
03/04/2004 | US20040043069 Stable oral formulation containing benzimidazole derivative |
03/04/2004 | US20040043068 Supplying nitrogen oxide to vascular system; prevent restenosis; cardiovascular disorders; antiischemic agents |
03/04/2004 | US20040043067 Fluorosiloxane matrix controlled diffusion drug delivery systems |
03/04/2004 | US20040043066 Levothyroxine compositions having unique triiodothyronine Tmax properties |
03/04/2004 | US20040043065 Controlled release formulations containing an active ingredient, preferably melatonin, and the method of preparation |
03/04/2004 | US20040043064 Active material enclosured in impervious layer; capsule |
03/04/2004 | US20040043062 Containing herbs; transdermal; sustained release |
03/04/2004 | US20040043061 Dissolvable films comprising suspended, non-soluble pharmaceutically active ingredients, apparatus and methods for their manufacture and use |
03/04/2004 | US20040043059 Flat sheet with adhesive substrate; convex frame; aging and oxidation resistance |
03/04/2004 | US20040043043 Gelling, thickening solutions of water soluble vitamins with triglycerides and emulsifiers |
03/04/2004 | US20040043041 Antimicrobial compositions and methods of use |
03/04/2004 | US20040043038 Vaccines |
03/04/2004 | US20040043007 Transfection system |
03/04/2004 | US20040043006 Tissue regenerative composition |
03/04/2004 | US20040043003 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions |
03/04/2004 | US20040043001 Pharmaceutical formulations of antineoplastic agents and processes of making and using the same |
03/04/2004 | US20040042973 Anhydrous mometasome furoate mixture with surfactant and propellant; pressurized vessel; controlling particle size distribution |
03/04/2004 | US20040042972 Spray freeze dry of compositions for intranasal administration |
03/04/2004 | US20040042971 Spray freeze dry of compositions for pulmonary administration |